Global and Japan Injectable Drug Delivery Formulation Market Insights, Forecast to 2027
Table of Contents1 Study Coverage
1.1 Injectable Drug Delivery Formulation Product Introduction
1.2 Market by Type
1.2.1 Global Injectable Drug Delivery Formulation Market Size Growth Rate by Type
1.2.2 Conventional Drug Delivery Formulations
1.2.3 Novel Drug Delivery Formulations
1.2.4 Long-acting Formulations
1.3 Market by Application
1.3.1 Global Injectable Drug Delivery Formulation Market Size Growth Rate by Application
1.3.2 Autoimmune Diseases
1.3.3 Hormonal Disorders
1.3.4 Oncology
1.3.5 Orphan Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Injectable Drug Delivery Formulation Market Size, Estimates and Forecasts
2.1.1 Global Injectable Drug Delivery Formulation Revenue 2016-2027
2.1.2 Global Injectable Drug Delivery Formulation Sales 2016-2027
2.2 Global Injectable Drug Delivery Formulation, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Injectable Drug Delivery Formulation Historical Market Size by Region (2016-2021)
2.3.1 Global Injectable Drug Delivery Formulation Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Injectable Drug Delivery Formulation Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Injectable Drug Delivery Formulation Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Injectable Drug Delivery Formulation Sales Forecast by Region (2022-2027)
2.4.2 Global Injectable Drug Delivery Formulation Revenue Forecast by Region (2022-2027)
3 Global Injectable Drug Delivery Formulation Competitor Landscape by Players
3.1 Global Top Injectable Drug Delivery Formulation Manufacturers by Sales
3.1.1 Global Injectable Drug Delivery Formulation Sales by Manufacturer (2016-2021)
3.1.2 Global Injectable Drug Delivery Formulation Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Injectable Drug Delivery Formulation Manufacturers by Revenue
3.2.1 Key Injectable Drug Delivery Formulation Manufacturers Covered: Ranking by Revenue
3.2.2 Global Injectable Drug Delivery Formulation Revenue by Manufacturers (2016-2021)
3.2.3 Global Injectable Drug Delivery Formulation Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Injectable Drug Delivery Formulation Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Injectable Drug Delivery Formulation Revenue in 2020
3.2.6 Global Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Injectable Drug Delivery Formulation Price by Manufacturers
3.4 Global Injectable Drug Delivery Formulation Manufacturing Base Distribution, Product Types
3.4.1 Injectable Drug Delivery Formulation Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Injectable Drug Delivery Formulation Product Type
3.4.3 Date of International Manufacturers Enter into Injectable Drug Delivery Formulation Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Injectable Drug Delivery Formulation Market Size by Type (2016-2021)
4.1.1 Global Injectable Drug Delivery Formulation Sales by Type (2016-2021)
4.1.2 Global Injectable Drug Delivery Formulation Revenue by Type (2016-2021)
4.1.3 Injectable Drug Delivery Formulation Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Injectable Drug Delivery Formulation Market Size Forecast by Type (2022-2027)
4.2.1 Global Injectable Drug Delivery Formulation Sales Forecast by Type (2022-2027)
4.2.2 Global Injectable Drug Delivery Formulation Revenue Forecast by Type (2022-2027)
4.2.3 Injectable Drug Delivery Formulation Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Injectable Drug Delivery Formulation Market Size by Application (2016-2021)
5.1.1 Global Injectable Drug Delivery Formulation Sales by Application (2016-2021)
5.1.2 Global Injectable Drug Delivery Formulation Revenue by Application (2016-2021)
5.1.3 Injectable Drug Delivery Formulation Price by Application (2016-2021)
5.2 Injectable Drug Delivery Formulation Market Size Forecast by Application (2022-2027)
5.2.1 Global Injectable Drug Delivery Formulation Sales Forecast by Application (2022-2027)
5.2.2 Global Injectable Drug Delivery Formulation Revenue Forecast by Application (2022-2027)
5.2.3 Global Injectable Drug Delivery Formulation Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Injectable Drug Delivery Formulation Market Size YoY Growth 2016-2027
6.1.1 Japan Injectable Drug Delivery Formulation Sales YoY Growth 2016-2027
6.1.2 Japan Injectable Drug Delivery Formulation Revenue YoY Growth 2016-2027
6.1.3 Japan Injectable Drug Delivery Formulation Market Share in Global Market 2016-2027
6.2 Japan Injectable Drug Delivery Formulation Market Size by Players (International and Local Players)
6.2.1 Japan Top Injectable Drug Delivery Formulation Players by Sales (2016-2021)
6.2.2 Japan Top Injectable Drug Delivery Formulation Players by Revenue (2016-2021)
6.3 Japan Injectable Drug Delivery Formulation Historic Market Review by Type (2016-2021)
6.3.1 Japan Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2021)
6.3.2 Japan Injectable Drug Delivery Formulation Revenue Market Share by Type (2016-2021)
6.3.3 Japan Injectable Drug Delivery Formulation Price by Type (2016-2021)
6.4 Japan Injectable Drug Delivery Formulation Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Injectable Drug Delivery Formulation Sales Forecast by Type (2022-2027)
6.4.2 Japan Injectable Drug Delivery Formulation Revenue Forecast by Type (2022-2027)
6.4.3 Japan Injectable Drug Delivery Formulation Price Forecast by Type (2022-2027)
6.5 Japan Injectable Drug Delivery Formulation Historic Market Review by Application (2016-2021)
6.5.1 Japan Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2021)
6.5.2 Japan Injectable Drug Delivery Formulation Revenue Market Share by Application (2016-2021)
6.5.3 Japan Injectable Drug Delivery Formulation Price by Application (2016-2021)
6.6 Japan Injectable Drug Delivery Formulation Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Injectable Drug Delivery Formulation Sales Forecast by Application (2022-2027)
6.6.2 Japan Injectable Drug Delivery Formulation Revenue Forecast by Application (2022-2027)
6.6.3 Japan Injectable Drug Delivery Formulation Price Forecast by Application (2022-2027)
7 North America
7.1 North America Injectable Drug Delivery Formulation Market Size YoY Growth 2016-2027
7.2 North America Injectable Drug Delivery Formulation Market Facts & Figures by Country
7.2.1 North America Injectable Drug Delivery Formulation Sales by Country (2016-2021)
7.2.2 North America Injectable Drug Delivery Formulation Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Injectable Drug Delivery Formulation Market Size YoY Growth 2016-2027
8.2 Asia Pacific Injectable Drug Delivery Formulation Market Facts & Figures by Region
8.2.1 Asia Pacific Injectable Drug Delivery Formulation Sales by Region (2016-2021)
8.2.2 Asia Pacific Injectable Drug Delivery Formulation Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Injectable Drug Delivery Formulation Market Size YoY Growth 2016-2027
9.2 Europe Injectable Drug Delivery Formulation Market Facts & Figures by Country
9.2.1 Europe Injectable Drug Delivery Formulation Sales by Country (2016-2021)
9.2.2 Europe Injectable Drug Delivery Formulation Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Injectable Drug Delivery Formulation Market Size YoY Growth 2016-2027
10.2 Latin America Injectable Drug Delivery Formulation Market Facts & Figures by Country
10.2.1 Latin America Injectable Drug Delivery Formulation Sales by Country (2016-2021)
10.2.2 Latin America Injectable Drug Delivery Formulation Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Injectable Drug Delivery Formulation Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Injectable Drug Delivery Formulation Market Facts & Figures by Country
11.2.1 Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2016-2021)
11.2.2 Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Becton, Dickinson and Company (US)
12.1.1 Becton, Dickinson and Company (US) Corporation Information
12.1.2 Becton, Dickinson and Company (US) Description and Business Overview
12.1.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Products Offered
12.1.5 Becton, Dickinson and Company (US) Recent Development
12.2 Baxter International Inc. (US)
12.2.1 Baxter International Inc. (US) Corporation Information
12.2.2 Baxter International Inc. (US) Description and Business Overview
12.2.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Baxter International Inc. (US) Injectable Drug Delivery Formulation Products Offered
12.2.5 Baxter International Inc. (US) Recent Development
12.3 Gerresheimer AG (Germany)
12.3.1 Gerresheimer AG (Germany) Corporation Information
12.3.2 Gerresheimer AG (Germany) Description and Business Overview
12.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Products Offered
12.3.5 Gerresheimer AG (Germany) Recent Development
12.4 Pfizer, Inc. (US)
12.4.1 Pfizer, Inc. (US) Corporation Information
12.4.2 Pfizer, Inc. (US) Description and Business Overview
12.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Products Offered
12.4.5 Pfizer, Inc. (US) Recent Development
12.5 Schott AG (Germany)
12.5.1 Schott AG (Germany) Corporation Information
12.5.2 Schott AG (Germany) Description and Business Overview
12.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Schott AG (Germany) Injectable Drug Delivery Formulation Products Offered
12.5.5 Schott AG (Germany) Recent Development
12.6 Sandoz (Germany)
12.6.1 Sandoz (Germany) Corporation Information
12.6.2 Sandoz (Germany) Description and Business Overview
12.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sandoz (Germany) Injectable Drug Delivery Formulation Products Offered
12.6.5 Sandoz (Germany) Recent Development
12.7 Teva Pharmaceutical Industries Ltd. (Israel)
12.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
12.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Description and Business Overview
12.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Products Offered
12.7.5 Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
12.8 Eli Lilly and Company (US)
12.8.1 Eli Lilly and Company (US) Corporation Information
12.8.2 Eli Lilly and Company (US) Description and Business Overview
12.8.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Products Offered
12.8.5 Eli Lilly and Company (US) Recent Development
12.11 Becton, Dickinson and Company (US)
12.11.1 Becton, Dickinson and Company (US) Corporation Information
12.11.2 Becton, Dickinson and Company (US) Description and Business Overview
12.11.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Products Offered
12.11.5 Becton, Dickinson and Company (US) Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Injectable Drug Delivery Formulation Industry Trends
13.2 Injectable Drug Delivery Formulation Market Drivers
13.3 Injectable Drug Delivery Formulation Market Challenges
13.4 Injectable Drug Delivery Formulation Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Injectable Drug Delivery Formulation Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Global Injectable Drug Delivery Formulation Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Conventional Drug Delivery Formulations
Table 3. Major Manufacturers of Novel Drug Delivery Formulations
Table 4. Major Manufacturers of Long-acting Formulations
Table 5. Global Injectable Drug Delivery Formulation Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 6. Global Injectable Drug Delivery Formulation Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Injectable Drug Delivery Formulation Sales by Regions (2016-2021) & (K Pcs)
Table 8. Global Injectable Drug Delivery Formulation Sales Market Share by Regions (2016-2021)
Table 9. Global Injectable Drug Delivery Formulation Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Injectable Drug Delivery Formulation Sales Forecast by Region (2022-2027) & (K Pcs)
Table 11. Global Injectable Drug Delivery Formulation Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Injectable Drug Delivery Formulation Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Injectable Drug Delivery Formulation Sales by Manufacturers (2016-2021) (K Pcs)
Table 15. Global Injectable Drug Delivery Formulation Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Injectable Drug Delivery Formulation Manufacturers by Revenue (US$ Million) in 2020
Table 17. Injectable Drug Delivery Formulation Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Injectable Drug Delivery Formulation Revenue Share by Manufacturers (2016-2021)
Table 19. Global Injectable Drug Delivery Formulation Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Injectable Drug Delivery Formulation by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Drug Delivery Formulation as of 2020)
Table 21. Key Manufacturers Injectable Drug Delivery Formulation Price (2016-2021) (USD/Pcs)
Table 22. Injectable Drug Delivery Formulation Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Injectable Drug Delivery Formulation Product Type
Table 24. Date of International Manufacturers Enter into Injectable Drug Delivery Formulation Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Injectable Drug Delivery Formulation Sales by Type (2016-2021) (K Pcs)
Table 27. Global Injectable Drug Delivery Formulation Sales Share by Type (2016-2021)
Table 28. Global Injectable Drug Delivery Formulation Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Injectable Drug Delivery Formulation Revenue Share by Type (2016-2021)
Table 30. Injectable Drug Delivery Formulation Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 31. Global Injectable Drug Delivery Formulation Sales Forecast by Type (2022-2027) & (K Pcs)
Table 32. Global Injectable Drug Delivery Formulation Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Injectable Drug Delivery Formulation Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Injectable Drug Delivery Formulation Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 36. Global Injectable Drug Delivery Formulation Sales by Application (2016-2021) (K Pcs)
Table 37. Global Injectable Drug Delivery Formulation Sales Share by Application (2016-2021)
Table 38. Global Injectable Drug Delivery Formulation Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Injectable Drug Delivery Formulation Revenue Share by Application (2016-2021)
Table 40. Injectable Drug Delivery Formulation Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 41. Global Injectable Drug Delivery Formulation Sales Forecast by Application (2022-2027) & (K Pcs)
Table 42. Global Injectable Drug Delivery Formulation Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Injectable Drug Delivery Formulation Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Injectable Drug Delivery Formulation Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 46. Japan Injectable Drug Delivery Formulation Sales (K Pcs) of Key Companies (2016-2021)
Table 47. Japan Injectable Drug Delivery Formulation Sales Share by Company (2016-2021)
Table 48. Japan Injectable Drug Delivery Formulation Revenue (US$ Million) by Company (2016-2021)
Table 49. Japan Injectable Drug Delivery Formulation Revenue Share by Company (2016-2021)
Table 50. Japan Injectable Drug Delivery Formulation Sales (K Pcs) by Type (2016-2021)
Table 51. Japan Injectable Drug Delivery Formulation Sales Share by Type (2016-2021)
Table 52. Japan Injectable Drug Delivery Formulation Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. Japan Injectable Drug Delivery Formulation Price (USD/Pcs) by Type (2016-2021)
Table 54. Japan Injectable Drug Delivery Formulation Sales (K Pcs) by Type (2022-2027)
Table 55. Japan Injectable Drug Delivery Formulation Sales Share by Type (2022-2027)
Table 56. Japan Injectable Drug Delivery Formulation Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. Japan Injectable Drug Delivery Formulation Revenue Share by Type (2022-2027)
Table 58. Japan Injectable Drug Delivery Formulation Price (USD/Pcs) by Type (2022-2027)
Table 59. Japan Injectable Drug Delivery Formulation Sales (K Pcs) by Application (2016-2021)
Table 60. Japan Injectable Drug Delivery Formulation Sales Share by Application (2016-2021)
Table 61. Japan Injectable Drug Delivery Formulation Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. Japan Injectable Drug Delivery Formulation Price (USD/Pcs) by Application (2016-2021)
Table 63. Japan Injectable Drug Delivery Formulation Sales (K Pcs) by Application (2022-2027)
Table 64. Japan Injectable Drug Delivery Formulation Sales Share by Application (2022-2027)
Table 65. Japan Injectable Drug Delivery Formulation Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. Japan Injectable Drug Delivery Formulation Revenue Share by Application (2022-2027)
Table 67. Japan Injectable Drug Delivery Formulation Price (USD/Pcs) by Application (2022-2027)
Table 68. North America Injectable Drug Delivery Formulation Sales by Country (2016-2021) & (K Pcs)
Table 69. North America Injectable Drug Delivery Formulation Sales Market Share by Country (2016-2021)
Table 70. North America Injectable Drug Delivery Formulation Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Injectable Drug Delivery Formulation Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Injectable Drug Delivery Formulation Sales by Region (2016-2021) & (K Pcs)
Table 73. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Injectable Drug Delivery Formulation Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Injectable Drug Delivery Formulation Revenue Market Share by Region (2016-2021)
Table 76. Europe Injectable Drug Delivery Formulation Sales by Country (2016-2021) & (K Pcs)
Table 77. Europe Injectable Drug Delivery Formulation Sales Market Share by Country (2016-2021)
Table 78. Europe Injectable Drug Delivery Formulation Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country (2016-2021)
Table 80. Latin America Injectable Drug Delivery Formulation Sales by Country (2016-2021) & (K Pcs)
Table 81. Latin America Injectable Drug Delivery Formulation Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Injectable Drug Delivery Formulation Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Injectable Drug Delivery Formulation Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2016-2021) & (K Pcs)
Table 85. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Injectable Drug Delivery Formulation Revenue Market Share by Country (2016-2021)
Table 88. Becton, Dickinson and Company (US) Corporation Information
Table 89. Becton, Dickinson and Company (US) Description and Business Overview
Table 90. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product
Table 92. Becton, Dickinson and Company (US) Recent Development
Table 93. Baxter International Inc. (US) Corporation Information
Table 94. Baxter International Inc. (US) Description and Business Overview
Table 95. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Baxter International Inc. (US) Product
Table 97. Baxter International Inc. (US) Recent Development
Table 98. Gerresheimer AG (Germany) Corporation Information
Table 99. Gerresheimer AG (Germany) Description and Business Overview
Table 100. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Gerresheimer AG (Germany) Product
Table 102. Gerresheimer AG (Germany) Recent Development
Table 103. Pfizer, Inc. (US) Corporation Information
Table 104. Pfizer, Inc. (US) Description and Business Overview
Table 105. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Pfizer, Inc. (US) Product
Table 107. Pfizer, Inc. (US) Recent Development
Table 108. Schott AG (Germany) Corporation Information
Table 109. Schott AG (Germany) Description and Business Overview
Table 110. Schott AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Schott AG (Germany) Product
Table 112. Schott AG (Germany) Recent Development
Table 113. Sandoz (Germany) Corporation Information
Table 114. Sandoz (Germany) Description and Business Overview
Table 115. Sandoz (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Sandoz (Germany) Product
Table 117. Sandoz (Germany) Recent Development
Table 118. Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
Table 119. Teva Pharmaceutical Industries Ltd. (Israel) Description and Business Overview
Table 120. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Teva Pharmaceutical Industries Ltd. (Israel) Product
Table 122. Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
Table 123. Eli Lilly and Company (US) Corporation Information
Table 124. Eli Lilly and Company (US) Description and Business Overview
Table 125. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 126. Eli Lilly and Company (US) Product
Table 127. Eli Lilly and Company (US) Recent Development
Table 128. Injectable Drug Delivery Formulation Market Trends
Table 129. Injectable Drug Delivery Formulation Market Drivers
Table 130. Injectable Drug Delivery Formulation Market Challenges
Table 131. Injectable Drug Delivery Formulation Market Restraints
Table 132. Injectable Drug Delivery Formulation Customers List
Table 133. Injectable Drug Delivery Formulation Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of FiguresFigure 1. Injectable Drug Delivery Formulation Product Picture
Figure 2. Global Injectable Drug Delivery Formulation Sales Market Share by Type in 2020 & 2027
Figure 3. Conventional Drug Delivery Formulations Product Picture
Figure 4. Novel Drug Delivery Formulations Product Picture
Figure 5. Long-acting Formulations Product Picture
Figure 6. Global Injectable Drug Delivery Formulation Sales Market Share by Application in 2020 & 2027
Figure 7. Autoimmune Diseases
Figure 8. Hormonal Disorders
Figure 9. Oncology
Figure 10. Orphan Diseases
Figure 11. Others
Figure 12. Injectable Drug Delivery Formulation Report Years Considered
Figure 13. Global Injectable Drug Delivery Formulation Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Injectable Drug Delivery Formulation Market Size 2016-2027 (US$ Million)
Figure 15. Global Injectable Drug Delivery Formulation Sales 2016-2027 (K Pcs)
Figure 16. Global Injectable Drug Delivery Formulation Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2016-2021)
Figure 18. Global Injectable Drug Delivery Formulation Sales Market Share by Region in 2020
Figure 19. Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2016-2021)
Figure 20. Global Injectable Drug Delivery Formulation Revenue Market Share by Region in 2020
Figure 21. Global Injectable Drug Delivery Formulation Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Injectable Drug Delivery Formulation Revenue in 2020
Figure 23. Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2021)
Figure 25. Global Injectable Drug Delivery Formulation Sales Market Share by Type in 2020
Figure 26. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2016-2021)
Figure 27. Global Injectable Drug Delivery Formulation Revenue Market Share by Type in 2020
Figure 28. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2021)
Figure 29. Global Injectable Drug Delivery Formulation Sales Market Share by Application in 2020
Figure 30. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2016-2021)
Figure 31. Global Injectable Drug Delivery Formulation Revenue Market Share by Application in 2020
Figure 32. Japan Injectable Drug Delivery Formulation Sales Growth Rate 2016-2027 (K Pcs)
Figure 33. Japan Injectable Drug Delivery Formulation Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. Japan Injectable Drug Delivery Formulation Market Share in Global Market 2016-2027
Figure 35. Japan 5 and 10 Largest Injectable Drug Delivery Formulation Players Market Share by Revenue in Injectable Drug Delivery Formulation in 2020
Figure 36. Japan Injectable Drug Delivery Formulation Revenue Share by Type (2016-2021)
Figure 37. Japan Injectable Drug Delivery Formulation Revenue Growth Rate by Type in 2016 & 2020
Figure 38. Japan Injectable Drug Delivery Formulation Revenue Share by Application (2016-2021)
Figure 39. Japan Injectable Drug Delivery Formulation Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Injectable Drug Delivery Formulation Sales Growth Rate 2016-2021 (K Pcs)
Figure 41. North America Injectable Drug Delivery Formulation Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Injectable Drug Delivery Formulation Sales Market Share by Country in 2020
Figure 43. North America Injectable Drug Delivery Formulation Revenue Market Share by Country in 2020
Figure 44. U.S. Injectable Drug Delivery Formulation Sales Growth Rate (2016-2021) (K Pcs)
Figure 45. U.S. Injectable Drug Delivery Formulation Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Injectable Drug Delivery Formulation Sales Growth Rate (2016-2021) (K Pcs)
Figure 47. Canada Injectable Drug Delivery Formulation Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe Injectable Drug Delivery Formulation Sales Growth Rate 2016-2021 (K Pcs)
Figure 49. Europe Injectable Drug Delivery Formulation Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe Injectable Drug Delivery Formulation Sales Market Share by Country in 2020
Figure 51. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country in 2020
Figure 52. Germany Injectable Drug Delivery Formulation Sales Growth Rate (2016-2021) (K Pcs)
Figure 53. Germany Injectable Drug